Salix Pharmaceuticals Ltd (SLXP)

172.81
0.16 0.09
NASDAQ : Health Care
Prev Close 172.65
Open 172.72
Day Low/High 172.71 / 172.96
52 Wk Low/High 86.00 / 172.98
Volume 4.30M
Avg Volume 3.38M
Exchange NASDAQ
Shares Outstanding 64.25M
Market Cap 11.10B
EPS -6.53
P/E Ratio N/A
Div & Yield N.A. (N.A)
Watch Out: Barbarians At The Gate For Salix Pharmaceuticals (SLXP)

Watch Out: Barbarians At The Gate For Salix Pharmaceuticals (SLXP)

Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

Salix Announces The Promotion Of William P. Forbes, PharmD To President, Medical, R&D And Chief Development Officer

Salix Announces The Promotion Of William P. Forbes, PharmD To President, Medical, R&D And Chief Development Officer

Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) ("Salix" or the "Company") today announced the promotion of William P.

Federman & Sherwood Investigates Salix Pharmaceuticals, Ltd. For Possible Violations Of Federal Securities Laws

Federman & Sherwood Investigates Salix Pharmaceuticals, Ltd. For Possible Violations Of Federal Securities Laws

The law firm of Federman & Sherwood has launched an investigation into Salix Pharmaceuticals, Ltd.

Salix Provides Update On Audit Committee Review

Salix Provides Update On Audit Committee Review

Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) ("Salix" or the "Company") today announced that the Audit Committee of Salix's Board of Directors (the "Audit Committee"), in consultation with its outside advisors and management,...

Salix Pharmaceuticals (SLXP) Shares Cross Above 200 DMA

Salix Pharmaceuticals (SLXP) Shares Cross Above 200 DMA

In trading on Tuesday, shares of Salix Pharmaceuticals Ltd crossed above their 200 day moving average of $125.40, changing hands as high as $130.00 per share. Salix Pharmaceuticals Ltd shares are currently trading up about 4.7% on the day.

Salix Pharmaceuticals (SLXP) Is Today's Storm The Castle Stock

Salix Pharmaceuticals (SLXP) Is Today's Storm The Castle Stock

Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a "storm the castle" (crossing above the 200-day simple moving average on higher than normal relative volume) candidate

Pharming And Salix Announce First Patient Treated In Clinical Study Of Ruconest® For Prophylaxis Of Hereditary Angioedema

Pharming And Salix Announce First Patient Treated In Clinical Study Of Ruconest® For Prophylaxis Of Hereditary Angioedema

Pharming Group NV (EURONEXT: PHARM) and Salix Pharmaceuticals, Ltd.

Carolyn Logan To Retire As Chief Executive Officer Of Salix Pharmaceuticals

Carolyn Logan To Retire As Chief Executive Officer Of Salix Pharmaceuticals

Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) ("Salix" or the "Company") today announced that Carolyn Logan has informed the Board of her decision to retire as President and Chief Executive Officer, and as a director, of the...

SLXP Investor Alert: Levi & Korsinsky, LLP Reminds Investors Of Class Action Against Salix Pharmaceuticals, Ltd. And Its Board Of Directors And A Lead Plaintiff Deadline Of January 6, 2015

SLXP Investor Alert: Levi & Korsinsky, LLP Reminds Investors Of Class Action Against Salix Pharmaceuticals, Ltd. And Its Board Of Directors And A Lead Plaintiff Deadline Of January 6, 2015

Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased Salix Pharmaceuticals, Ltd.

INVESTOR ALERT: Investors Of Salix Pharmaceuticals, Ltd. With Losses Of $100,000 Or More Are Encouraged To Contact Glancy Binkow & Goldberg LLP

INVESTOR ALERT: Investors Of Salix Pharmaceuticals, Ltd. With Losses Of $100,000 Or More Are Encouraged To Contact Glancy Binkow & Goldberg LLP

Glancy Binkow & Goldberg LLP reminds investors of Salix Pharmaceuticals, Ltd.

Lieff Cabraser Reminds Salix Pharmaceuticals, Inc. Investors Of January 6, 2015 Lead Plaintiff Deadline In Class Litigation - SLXP

Lieff Cabraser Reminds Salix Pharmaceuticals, Inc. Investors Of January 6, 2015 Lead Plaintiff Deadline In Class Litigation - SLXP

The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds Salix Pharmaceuticals, Inc.

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Salix Pharmaceuticals, Ltd. To Contact Brower Piven Before The January 6, 2015 Lead Plaintiff Deadline In Class Action Lawsuit

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Salix Pharmaceuticals, Ltd. To Contact Brower Piven Before The January 6, 2015 Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...

Salix Pharmaceuticals Provides Updates On Wholesaler Inventory Reductions And The XIFAXAN® 550 For IBS-D Approval Timeline, And Provides Preliminary Guidance For 2015 And 2016

Salix Pharmaceuticals Provides Updates On Wholesaler Inventory Reductions And The XIFAXAN® 550 For IBS-D Approval Timeline, And Provides Preliminary Guidance For 2015 And 2016

Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) ("Salix" or the "Company") today announced that it is working cooperatively with its principal pharmaceutical wholesalers to accelerate the reduction of wholesaler inventory levels...

SLXP SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors Of Class Action Against Salix Pharmaceuticals, Ltd. And Its Board Of Directors And A Lead Plaintiff Deadline Of January 6, 2015

SLXP SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors Of Class Action Against Salix Pharmaceuticals, Ltd. And Its Board Of Directors And A Lead Plaintiff Deadline Of January 6, 2015

Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased Salix Pharmaceuticals, Ltd.

Jim Cramer's 'Mad Money' Recap: Google Is Better Than the Market Thinks

Jim Cramer's 'Mad Money' Recap: Google Is Better Than the Market Thinks

After a lackluster year, Cramer expects Google to deliver solid results come January when it reports earnings.

INVESTOR ALERT: Class Action Lawsuit Against Salix Pharmaceuticals, Ltd. Announced By Law Offices Of Howard G. Smith

INVESTOR ALERT: Class Action Lawsuit Against Salix Pharmaceuticals, Ltd. Announced By Law Offices Of Howard G. Smith

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of purchasers of the securities of Salix ...

Salix Pharmaceuticals Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors

Salix Pharmaceuticals Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers Taylor LLP announce that a class action lawsuit...

Salix Pharmaceuticals Announces Plan To Augment Board Of Directors

Salix Pharmaceuticals Announces Plan To Augment Board Of Directors

Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) ("Salix" or the "Company") today announced that it has engaged Russell Reynolds Associates, a nationally recognized search firm, to conduct a comprehensive search to assist...

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Salix Pharmaceuticals, Ltd. To Contact Brower Piven Before The January 6, 2015 Lead Plaintiff Deadline In Class Action Lawsuit

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Salix Pharmaceuticals, Ltd. To Contact Brower Piven Before The January 6, 2015 Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on...

Lieff Cabraser Announces Class Action Litigation Against Salix Pharmaceuticals, Inc. - SLXP

Lieff Cabraser Announces Class Action Litigation Against Salix Pharmaceuticals, Inc. - SLXP

The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been brought on behalf of those who purchased or otherwise acquired the securities of Salix Pharmaceuticals, Inc.

Trade-Ideas: Salix Pharmaceuticals (SLXP) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas: Salix Pharmaceuticals (SLXP) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a "dead cat bounce" (down big yesterday but up big today) candidate

Salix Pharmaceuticals (SLXP) Downgraded From Buy to Hold

Salix Pharmaceuticals (SLXP) Downgraded From Buy to Hold

Salix Pharmaceuticals SLXP has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C+. TheStreet Ratings Team has this to say about their recommendation:

'Fast Money' Recap: When Is the Best Time to Buy Twitter Stock?

'Fast Money' Recap: When Is the Best Time to Buy Twitter Stock?

The trading panel discussed whether it would help or hurt Twitter if its CEO steps down and whether Coca-Cola has any fizz left in it.

Federman & Sherwood Investigates Salix Pharmaceuticals, Ltd. For Possible Violations Of Federal Securities Laws

Federman & Sherwood Investigates Salix Pharmaceuticals, Ltd. For Possible Violations Of Federal Securities Laws

The law firm of Federman & Sherwood has launched an investigation into Salix Pharmaceuticals, Ltd.

Market News: Sears, Salix Pharmaceuticals, Walt Disney

Market News: Sears, Salix Pharmaceuticals, Walt Disney

The Department of Labor reported that American companies added 214,000 jobs and the unemployment rate declined to 5.8%The stock markets in the United States fluctuated and eventually ended the trading...

Stock Market Today: Dow Scores Third Straight Record Close on Jobs Data

Stock Market Today: Dow Scores Third Straight Record Close on Jobs Data

The Dow Jones Industrial Average posts a small gain in the final minutes to closing bell, just enough to cement the index's third consecutive record close.

SHAREHOLDER ALERT: Investigation On Behalf Of Salix Pharmaceuticals, Ltd. Investors Announced By Law Offices Of Howard G. Smith

SHAREHOLDER ALERT: Investigation On Behalf Of Salix Pharmaceuticals, Ltd. Investors Announced By Law Offices Of Howard G. Smith

Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Salix Pharmaceuticals, Ltd.